Evidence map›Paper›PMID 41976154›Full record

ArticleMolecules (Basel, Switzerland)2026

Identifying ICAM-1 as a Therapeutic Target for Cytokine Storm in Human Macrophages Through Integrative Bioinformatics Approaches.

Shaojun Chen, Dapeng Wu, Zhe Zheng, Yiyuan Luo, Lihua Zhang

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shaojun ChenDepartment of Traditional Chinese Medicine, Zhejiang Pharmaceutical University, Ningbo 315000, China.
Dapeng WuAffiliated Hospital, Nanjing University of Traditional Chinese Medicine, Nanjing 210023, China.
Zhe ZhengSchool of Pharmacy, Nanjing University of Traditional Chinese Medicine, Nanjing 210023, China.
Yiyuan LuoDepartment of Traditional Chinese Medicine, Zhejiang Pharmaceutical University, Ningbo 315000, China.
Lihua ZhangSchool of Health Management, Zhejiang Pharmaceutical University, Ningbo 315000, China.

Funding

Zhejiang Provincial Basic Public Welfare Research Project LTGY24H290005
6 · The paper itself

Abstract

Excessive macrophage activation is thought to be the primary cause of the cytokine storm that results in severe coronavirus disease 2019 (COVID-19) complications. The underlying mechanisms remain elusive, and more research is needed to find disease-critical genes and develop effective therapies. In this study, we used publicly accessible microarray datasets of cytokine storm in cultured human monocyte-derived macrophages challenged with cytokines, and employed bioinformatics, such as weighted gene co-expression network analysis (WGCNA) and differential expression analysis, to dissect gene expression profiles and identify putative disease-related molecules. Initially, three co-expression modules and related key genes were discovered, which highly correlated to macrophages challenged with cytokines. Then, a preliminary gene expression signature consisting of 203 upregulated and 24 downregulated genes was identified. Next, protein-protein interaction analysis and hub gene identification were used to identify 11 crucial hub genes, namely

Indexed as

Computational BiologyCytokine Release SyndromeIntercellular Adhesion Molecule-1MacrophagesCOVID-19CytokinesGene Expression ProfilingGene Expression RegulationGene Regulatory NetworksHumansProtein Interaction MapsSARS-CoV-2CytokinesICAM1 protein, humanIntercellular Adhesion Molecule-1COVID-19cytokine stormdasatinibgene expression signatureICAM-1weighted gene co-expression network analysis

Identifiers

PMID41976154
PMCPMC13075147

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.